2015
DOI: 10.1039/c4dt02217c
|View full text |Cite
|
Sign up to set email alerts
|

Fragmentation pathways analysis for the gas phase dissociation of protonated carnosine-oxaliplatin complexes

Abstract: Collision-induced dissociation (CID) experiments on the protonated carnosine-oxaliplatin complex, [Carnosine + OxPt + H](+) using several collision energies were shown to yield nine different fragment ions. Energy-resolved CID experiments on [Carnosine + OxPt + H](+) showed that the generation of the product ion [Carnosine - H + Pt(dach)](+) (where dach is 1,2-diaminocyclohexane) is the lowest energy process. At slightly higher collision energies, the loss of neutral carnosine from [Carnosine + OxPt + H](+) to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 70 publications
2
4
0
Order By: Relevance
“…The mass selection and subsequent CID of the entire isotopic envelope of the ion [Carnosine + CarbPt + H] + resulted in the MS spectrum shown in Figure . As was previously reported in the fragmentation of other platinum drug complexes to carnosine, , here there is also no difference in the fragmentation pathway of the [Carnosine + CarbPt + H] + complex among the different platinum isotopes. The generated product ion clusters centered around m / z 581, 564, 537, 520, 454, 437, 420, and 372 have been assigned as [Carnosine + CarbPt – NH 3 + H] + , [Carnosine + CarbPt – 2NH 3 + H] + , [Carnosine + CarbPt – NH 3 – CO 2 + H] + , [Carnosine + CarbPt – 2NH 3 – CO 2 + H] + , [Carnosine – H + Pt­(NH 3 ) 2 ] + , [Carnosine – H + Pt­(NH 3 )] + , [Carnosine – H + Pt] + , and [Carb + H] + , respectively.…”
Section: Resultssupporting
confidence: 86%
See 3 more Smart Citations
“…The mass selection and subsequent CID of the entire isotopic envelope of the ion [Carnosine + CarbPt + H] + resulted in the MS spectrum shown in Figure . As was previously reported in the fragmentation of other platinum drug complexes to carnosine, , here there is also no difference in the fragmentation pathway of the [Carnosine + CarbPt + H] + complex among the different platinum isotopes. The generated product ion clusters centered around m / z 581, 564, 537, 520, 454, 437, 420, and 372 have been assigned as [Carnosine + CarbPt – NH 3 + H] + , [Carnosine + CarbPt – 2NH 3 + H] + , [Carnosine + CarbPt – NH 3 – CO 2 + H] + , [Carnosine + CarbPt – 2NH 3 – CO 2 + H] + , [Carnosine – H + Pt­(NH 3 ) 2 ] + , [Carnosine – H + Pt­(NH 3 )] + , [Carnosine – H + Pt] + , and [Carb + H] + , respectively.…”
Section: Resultssupporting
confidence: 86%
“…The mass selection and subsequent CID of the entire isotopic envelope of the ion [Carnosine + CarbPt + H] + resulted in the MS 2 spectrum shown in Figure 3. As was previously reported in the fragmentation of other platinum drug complexes to carnosine, 58,38 here there is also no difference in the fragmentation pathway of the [Carnosine + All of the reported pathways start with the structural rearrangement of the most stable conformer, labeled 1A, of the precursor ion [Carnosine + CarbPt + H] + observed as the ion cluster around m/z 598, into conformer 1B, being 14.0 kcal mol −1 higher in energy. The structures of these two minima and transition state TS (1A→1B) allowing their interconversion are shown in Figure 4.…”
Section: Resultssupporting
confidence: 81%
See 2 more Smart Citations
“…Both instruments described here were previously successfully employed by us using the exact setup described to elucidate structures of metal and non-metal containing biological ligands. [37][38][39] While some of our previous studies were conducted under single collision conditions [40][41][42] the experiments reported here were all performed under multiple collision conditions.…”
Section: Instrumentationmentioning
confidence: 99%